Company Filing History:
Years Active: 1994-1995
Title: M J Crimmin: Innovator in Collagenase Inhibition
Introduction
M J Crimmin is a notable inventor based in Marlow Bottom, GB. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit collagenase activity. With a total of two patents to his name, Crimmin's work is pivotal in addressing diseases related to collagen degradation.
Latest Patents
Crimmin's latest patents focus on P2'-modified hydroxamic acid collagenase inhibitors. These compounds, represented by a general formula, exhibit collagenase inhibition activity. They are particularly useful in managing diseases such as rheumatoid arthritis, corneal ulceration, osteoporosis, periodontitis, gingivitis, and tumor invasion. The innovative nature of these compounds lies in their ability to target and inhibit collagen degradation, which is crucial for various medical applications.
Career Highlights
M J Crimmin is associated with British Bio-technology Limited, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic strategies for diseases involving collagen degradation.
Collaborations
Crimmin has collaborated with notable coworkers, including A H Davidson and R P Beckett. These partnerships have contributed to the successful development of his patented compounds.
Conclusion
M J Crimmin's innovative work in collagenase inhibitors showcases his commitment to advancing medical science. His contributions are essential for developing treatments for diseases that affect collagen, highlighting the importance of his research in the field.